
- Volume 0 0
Statins May Help Avert Colorectal Cancer
Patients taking statins on a regularbasis may reduce the odds of developingcolorectal cancer by 50%, according to astudy reported in the New England Journalof Medicine (May 26, 2005). The studycompared statin use by 1953 patients inIsrael who had been diagnosed with coloncancer between 1998 and 2004 with statinuse by a control group of 2015 participants.The 2 commonly used statin drugstaken by the study group were simvastatinand pravastatin.
The findings showed a 47% "relativereduction in the risk of colorectal cancerafter adjustment for other known riskfactors."Researcher Stephen B. Gruber,MD, PhD, said that more testing waswarranted because the absolute riskreduction was most likely low. He alsostressed that the current study is only anobservation in a selected population. Inorder to determine whether statins helpprotect against colorectal cancer, Dr.Gruber said that a randomized clinicaltrial that includes these medicines andother statins, compared with a placebo,is necessary.
Articles in this issue
over 20 years ago
Antibiotics, Probiotics, and Microfloraover 20 years ago
Calcium: An Essential Mineralover 20 years ago
CAN YOU READTHESE Rxs?over 20 years ago
ECKEL RECEIVES ALUMNI AWARDover 20 years ago
Cancer: Update on Biologicsover 20 years ago
Managing Chronic Pain: An Analysis of the Use of Opioidsover 20 years ago
PHARMACIST'S RIGHT TO CHOOSE?over 20 years ago
Teenage Drug Diversion—Part 2over 20 years ago
Is Altering Refills a Criminal Act?over 20 years ago
Do All SSRIs Interact the Same Way?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.